
Sign up to save your podcasts
Or


This week on the podcast Agustin discusses a perfect example of inefficiency in the biotech markets and why clinical data is all that matters when it comes to evaluating a biotech startup. He also briefly addresses what is up next for $MRNA, $NVAX, and the Delta variant.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
This week on the podcast Agustin discusses the recent pushback on the FDA's decision of Biogen's new Alzheimer's Drug and what that means for the future of neuroscience research and Medicare solvency. He also shares what could be a momentous event for one neuroscience company in particular and finally concludes the episode talking about Covid and what the future holds with the emergence and domination of the Delta variant.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
This week on the podcast Agustin discusses whether we will need booster shots to protect against future variants and provides a comprehensive overview of $CRIS and $KYMR
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
This week on the podcast Agustin discusses the breakthrough approval by the FDA for Biogen's Aduhelm and what that means for biotech in general and Biogen in particular. He also highlights the ultimate failure that has been CureVac ( $CVAC) in their Covid vaccine development.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
This week on the podcast Agustin discusses the upcoming readouts from ASCO 2021, highlights the current situation for Covid manufacturers including the over-inflated CureVac ( $CVAC), and celebrates the recent milestone for drug development and the implications on other manufacturers within the KRAS space.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
After two weeks away we are back with a girthy episode. This week on the podcast Agustin discusses the implications of removing patent protections for the covid vaccines, addresses the numerous delays with $NVAX and shares his thoughts on $TRIL
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
On this week's episode, Agustin discusses the recent Johnson & Johnson vaccine pause, the failure that is Inovio, and highlights how to navigate volatility within the biotech market!
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
On this week's episode, Agustin highlights the recent readouts at AACR of two companies $ONCT and $AFMD and what those readouts mean for the future!
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
On this week's episode, Agustin highlights the debacle of the $AZN covid vaccine, potential implications behind the Whitehouse policy to remove IP protections for covid therapeutic and vaccine manufacturers, and shares some updates on one pick that released some promising data in endometrial cancer.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Nothing to see here just more volatility! On this week's episode Agustin highlights the recent PR update from $TRIL, the lackluster data from $LLY and shares some insight on yet another newly public proteomics company except this one could become the next $ILMN!
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
From the publisher's feed